TESARO

+$0.02 (+0.03%) As of 8:00 PM UTC today

Why Robinhood?

You can watch TESARO and buy or sell other stocks, options, and ETFs commission-free!

About TSRO

Founded in 2010, TESARO is a privately held oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. The Company intends to leverage the experience and competencies of its management team to identify, acquire and develop promising drug candidates; and to commercialize safer and more effective products for the treatment and support of cancer patients.

CEO
Lonnie Moulder, Jr., MBA
Employees
—
Headquarters
Waltham, Massachusetts
Founded
2010

TSRO Key Statistics

Market cap
4.13B
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.68M
High today
—
Low today
—
Open price
—
Volume
0.00
52 Week high
$75.16
52 Week low
$23.41
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure